# Covance (Fortrea)

**Canonical:** https://apis.io/providers/covance/  
**Website:** https://www.fortrea.com  
**APIs profiled:** 0

Covance was a contract research organization (CRO) acquired by Labcorp in 2015 and rebranded as Labcorp Drug Development in 2021. In 2023, the clinical development business was spun off as Fortrea, an independent CRO headquartered in Durham, North Carolina, operating in 90+ countries and serving the pharmaceutical, biotechnology, and medical device industries with clinical trial management, central laboratory, and bioanalytical services. No public API or developer portal is currently published; integrations are arranged through sponsor and partner agreements.

## Kin Score — 3.8 / 100 (minimal)

Scored 2026-08-20 under rubric 0.12.0. Trend: flat (+0.0 from 3.8).

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Governance | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 0.0 |
| Developer Ergonomics | 2.4 |
| Commercial Clarity | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 0.0 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | no |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |

## Access

Unknown — onboarding: unknown, pricing: unknown, trial: no (confidence: low).

## Security (1)

- **Covance Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Bioanalytical, Biotechnology, Central Laboratory, Clinical Development, Clinical Trials, Contract Research Organization, CRO, Drug Development, Pharmaceuticals

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/covance/). Scores are computed from the provider's own public artifacts under a published rubric.